Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 166 active Myelodysplastic Syndrome trials
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
Study Type: Interventional Phase 2
Safety and Clinical Activity of KT-253 in Adult Patients With High Grade Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphoma, Solid Tumors
Study Type: Interventional Phase 1
A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
Study Type: Interventional Phase 1
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT
Study Type: Interventional Phase 1
Global PNH Patient Registry
Study Type: Observational
A Study of Bomedemstat (MK-3543) in Participants With Polycythemia Vera (MK-3543-004)
Study Type: Interventional Phase 2
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
Study Type: Interventional Phase 2
A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)
Study Type: Interventional Phase 2
There are 166 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now